Landau Jeffrey B

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$38,713.21

Insider Activity of Landau Jeffrey B

According to the SEC Form 4 filings, Landau Jeffrey B, being in a position of

  1. Chief Business Officer at CytomX Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 14820 shares for $24,452,
    over all time since 2022-07-19, has bought 0 shares, and sold 24622 shares for $38,713.

The largest sale of all time was on 2024-03-19 and amounted to 6562 shares of CytomX Therapeutics, Inc. for $13,685.

Biography of Landau Jeffrey B

No biography is available at this moment.

2024-08-20SaleCytomX Therapeutics, Inc.
CTMX
Chief Business Officer
4,181
0.0053%
$1.23$5,139-4.03%
2024-03-19SaleCytomX Therapeutics, Inc.
CTMX
Chief Business Officer
6,562
0.0093%
$2.09$13,685-28.9%
2023-12-20SaleCytomX Therapeutics, Inc.
CTMX
Chief Business Officer
4,077
0.0063%
$1.38$5,628+19.74%
2023-09-22SaleCytomX Therapeutics, Inc.
CTMX
Chief Business Officer
4,119
0.0063%
$1.30$5,356+14.06%
2023-03-16SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
1,477
0.0023%
$1.98$2,923-20.62%
2022-07-19SaleCytomX Therapeutics, Inc.
CTMX
Chief Business Officer
4,206
0.0061%
$1.42$5,982+10%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.